Get the Stockscreener App
5.19
7.23%
0.35
After Hours:
5.20
0.010
+0.19%
Bolt Biotherapeutics Inc stock is traded at $5.19, with a volume of 8,696.
It is up +7.23% in the last 24 hours and down -7.32% over the past month.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$4.84
Open:
$4.95
24h Volume:
8,696
Relative Volume:
0.45
Market Cap:
$9.96M
Revenue:
$7.88M
Net Income/Loss:
$-69.20M
P/E Ratio:
-2.8361
EPS:
-1.83
Net Cash Flow:
$-69.73M
1W Performance:
+1.17%
1M Performance:
-7.32%
6M Performance:
-41.69%
1Y Performance:
-60.08%
1-Day Range:
$4.95
$5.20
1-Week Range:
$4.8064
$5.281
52-Week Range:
$4.59
$14.36
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Name
Bolt Biotherapeutics Inc
Sector
Industry
Phone
650-665-9295
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.19 | 9.29M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-21 | Initiated | Guggenheim | Buy |
| Mar-02-21 | Initiated | Morgan Stanley | Overweight |
| Mar-02-21 | Initiated | SVB Leerink | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
Bolt Biotherapeutics Inc Stock (BOLT) Latest News
Applying chart zones and confluence areas to Bolt Biotherapeutics Inc.Dividend Hike & Free Accurate Trade Setup Notifications - Newser
Using data filters to optimize entry into Bolt Biotherapeutics Inc.Earnings Risk Report & Safe Entry Zone Identification - Newser
Quantitative breakdown of Bolt Biotherapeutics Inc. recent move2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Should you hold or exit Bolt Biotherapeutics Inc. now2025 EndofYear Setup & Fast Entry High Yield Tips - Newser
Can machine learning forecast Bolt Biotherapeutics Inc. recoveryJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Institutional scanner results for Bolt Biotherapeutics Inc.Market Weekly Review & Weekly Stock Performance Updates - Newser
Will Bolt Biotherapeutics Inc. price bounce be sustainableGDP Growth & Community Verified Trade Signals - Newser
Whale Trades: How does Bolt Biotherapeutics Inc. correlate with NasdaqMarket Trend Review & Short-Term Trading Opportunity Alerts - خودرو بانک
Q3 EPS Forecast for Bolt Biotherapeutics Raised by Analyst - Defense World
Price momentum metrics for Bolt Biotherapeutics Inc. explainedWeekly Profit Recap & AI Driven Price Forecasts - Newser
How does Bolt Biotherapeutics Inc. correlate with Nasdaq2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Is Bolt Biotherapeutics Inc. a speculative investment2025 Bull vs Bear & Free Growth Oriented Trading Recommendations - خودرو بانک
Is Bolt Biotherapeutics Inc. likely to announce a buybackEarnings Miss & AI Powered Buy and Sell Recommendations - sisaissue.com
Understanding Bolt Biotherapeutics Inc.’s price movementMarket Sentiment Report & Fast Entry High Yield Stock Tips - Newser
What Fibonacci levels say about Bolt Biotherapeutics Inc. rebound2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser
How to track smart money flows in Bolt Biotherapeutics Inc.Portfolio Risk Report & Fast Exit Strategy with Risk Control - Newser
Analyzing drawdowns of Bolt Biotherapeutics Inc. with statistical toolsTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
Long term hold vs stop loss in Bolt Biotherapeutics Inc.2025 Year in Review & Real-Time Volume Analysis Alerts - Newser
What’s the recovery path for long term holders of Bolt Biotherapeutics Inc.Market Risk Report & Fast Gain Stock Trading Tips - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stockEarnings Recap Summary & Fast Entry High Yield Tips - Newser
Bolt Biotherapeutics stock price target cut to $6 from $20 at Leerink Partners - Investing.com
Chart overlay techniques for tracking Bolt Biotherapeutics Inc.Global Markets & AI Forecast for Swing Trade Picks - Newser
Evaluating Bolt Biotherapeutics Inc. with trendline analysis2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Does Bolt Biotherapeutics Inc. qualify in momentum factor screeningEarnings Performance Report & Free Community Supported Trade Ideas - Newser
Smart tools for monitoring Bolt Biotherapeutics Inc.’s price action2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
How sentiment analysis helps forecast Bolt Biotherapeutics Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - Newser
Key resistance and support levels for Bolt Biotherapeutics Inc.July 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Is a relief rally coming for Bolt Biotherapeutics Inc. holdersGlobal Markets & Stock Timing and Entry Methods - Newser
Does Bolt Biotherapeutics Inc. have consistent dividend growthTrade Entry Report & Fast Entry Momentum Alerts - خودرو بانک
Can a trend reversal in Bolt Biotherapeutics Inc. lead to recoveryWeekly Stock Summary & Consistent Growth Equity Picks - Newser
RSI and MACD Indicate Shift in Bolt Biotherapeutics Inc. Sentiment getLinesFromResByArray error: size == 0 - thegnnews.com
Is Bolt Biotherapeutics Inc. stock forming a cup and handle2025 Top Gainers & Weekly Breakout Watchlists - خودرو بانک
How to forecast Bolt Biotherapeutics Inc. trends using time series2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
What is Bolt Biotherapeutics Inc. s P E ratio telling us2025 Earnings Impact & Daily Growth Stock Investment Tips - خودرو بانک
What is the dividend yield of Bolt Biotherapeutics Inc.2025 Price Targets & Smart Investment Allocation Tips - خودرو بانک
What recovery options are there for Bolt Biotherapeutics Inc.2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Trend analysis for Bolt Biotherapeutics Inc. this weekWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Bolt Biotherapeutics Inc Stock (BOLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bolt Biotherapeutics Inc Stock (BOLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quinn William P. | President, CEO and CFO |
Dec 16 '24 |
Buy |
0.50 |
2,500 |
1,241 |
41,272 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):